Qingning Liang

660 citations
9 papers · 561 indexed · h-index 8
Topics
Drug-Induced Hepatotoxicity and Protection (6 papers)Fibroblast Growth Factor Research (3 papers)Glutathione Transferases and Polymorphisms (2 papers)
Partner nations
ChinaHong KongAustralia

In The Last Decade

Qingning Liang

9 papers receiving 555 citations

Peers

Qingning Liang
Comparison fields: 5 of 84
  • Molecular Biology 351
  • Epidemiology 101
  • Physiology 99
  • Pharmacology 84
  • Surgery 49
Replace Zidong Donna Fu with:
Zidong Donna Fu United States
Emi Sasaki Japan
Shawna Wicks United States
L Mikulíková Czechia
Supriya R. Kulkarni United States
Laongdao Thongnak Thailand
Ki-Up Lee South Korea
Yaoyan Dun China
Zhifu Xie China
Qingning Liang relative to Zidong Donna Fu United States Zidong Donna Fu's profile →
Citations per field
00.5×1.5×
Zidong Donna Fu · 1×
Citations per year

Countries citing papers authored by Qingning Liang

Since Specialization
Citations

This map shows the geographic impact of Qingning Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingning Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingning Liang more than expected).

Fields of papers citing papers by Qingning Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingning Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingning Liang. The network helps show where Qingning Liang may publish in the future.

Co-authorship network of co-authors of Qingning Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Qingning Liang. A scholar is included among the top collaborators of Qingning Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingning Liang. Qingning Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 22
2 140
3 239
4 12
5 23
6 15
7 51
8 52
9
Pyrrolizidine alkaloid clivorine-induced oxidative stress injury in human normal liver L-02 cells.
7

About Qingning Liang

Qingning Liang is a scholar working on Pharmacology, Biochemistry and Hepatology, having authored 9 papers that have together received 561 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (6 papers), Fibroblast Growth Factor Research (3 papers) and Glutathione Transferases and Polymorphisms (2 papers). The work is most often cited by research in Pharmacology (84 citations), Molecular Biology (351 citations) and Endocrine and Autonomic Systems (26 citations). Qingning Liang has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Aimin Xu, Yu Wang, Hong Ding, Chris R. Triggle, Stefan R. Bornstein, Karen S.L. Lam, Ling Zhong, Jialiang Zhang, Lili Ji and Zhengtao Wang. Their work appears in journals such as PLoS ONE, Hepatology and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026